In 2020, over 57,000 Americans will be diagnosed with pancreatic cancer in the United States and over 47,000 will die from the disease.
Symptoms of pancreatic cancer include unintentional weight loss, abdominal discomfort, back pain, late development of type 2 diabetes, and even jaundice (yellowing of eyes and skin).
Around 93% of pancreatic cancers are exocrine tumors, the most common being adenocarcinoma.
Around 7% of pancreatic tumors are neuroendocrine tumors, known as islet cell tumors, which often grow slower than exocrine tumors.
Around 80% of pancreatic cancers are diagnosed in the later stages, making them more difficult to treat. Talk to your doctor if you have any symptoms!

Quicker access to pancreatic imaging and regular pancreatic surveillance has increased early diagnoses by around 14%! In early stages, pancreatic cancer is easier to treat and has a better survival rate.
There are over 500 pancreatic cancer clinical trials currently active in America! These trials will help find new treatments and better screening tools for pancreatic cancer.
Surgery outcomes have been steadily improving! A recent study found an improvement of over 20% since 2007 in the 2 years survival rate of patients after a pancreatectomy (having all or part of the pancreas removed) with or without radiation and chemotherapy.

Free Matching to Cancer Clinical Trials

Your match report contains a detailed list of cervical cancer clinical trials that you may be eligible to enroll in to receive unique and nonconventional treatment. Standard treatment is not the only option.
A patient advocate will review your report with you to answer any questions or concerns you may have and assist with enrollment if you decide to move forward with a trial.
There’s no need to travel to a clinical trial site until the enrollment process is complete.

Our number one priority is creating positive outcomes for cancer patients. Let us help you today.

Pancreatic Cancer